For retatrutide specifically, 12 mg weekly produces the largest loss but has the highest GI dropout rate, and 9 mg weekly gives nearly the same loss with better tolerability
Indeed, the SURPASS-CVOT study, which compares tirzepatide head-to-head with dulaglutide, will likely provide more comprehensive answers (expected by the end of 2024)
Proper storage of GLP-1 medications is essential to maintain their stability, efficacy, and safety
Patel helped develop and launch One Medicals Impact program, a chronic care management program utilizing digital health technology and a team-based approach to help patients manage their chronic conditions
Glucagon-like peptide-1 modulates RAW264.7 macrophage polarization by interfering with the JNK/STAT3 signaling pathway
Alexander JT, Staab EM, Wan W et al (2021) The longer-term benefits and harms of glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis